Atlas Trials

Beta-agonist Efficacy and Tolerability as Adjuvant Therapy in Myasthenia Gravis

Clinical trial NCT03914638 · UNKNOWN

Trial details

NCT number
NCT03914638
Sponsor
University of Aarhus
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Myasthenia Gravis
Start date
2019-04-01
Primary completion
2021-10-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.